Literature DB >> 7462423

Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver.

D L Avner, R G Lee, M M Berenson.   

Abstract

The pathogenesis of liver disease in protoporphyria has been presumed to result from the hepatic deposition of protoporphyrin. To examine the effects of protoporphyrin on hepatic bile flow and histopathology, studies were performed employing an isolated, in situ, rat liver perfusion system. Rat livers in the control group were perfused with 0-80 mumol sodium taurocholate/h. Rat livers in the experimental group were perfused with sodium taurocholate and (a) sufficient quantities of protoporphyrin to produce maximal canalicular secretion and (b) perfusate protoporphyrin concentrations of 0.01, 0.1, and 1 muM. The administration of protoporphyrin sufficient to achieve maximal canalicular secretion was found to significantly reduce bile flow in rats infused with 0, 40, and 80 mumol sodium taurocholate/h. Linear regression analysis defined the relationship between bile flow and biliary bile acid secretion and showed that the bile acid-independent fraction of bile flow was reduced (P < 0.01). Bile acid-dependent flow was unaffected and there was no significant difference in biliary bile acid secretion rates between control and protoporphyrin-perfused livers. Perfusion of rat livers with varying concentrations of protoporphyrin demonstrated the reduction of bile flow was dose-related. Analysis of perfusate enzyme activity did not reveal abnormalities that could account for the cholestasis. Studies to evaluate the effect of protoporphyrin on regional hepatic hemodynamics were inconclusive. Histopathological studies of control and protoporphyrin-perfused rat livers did not show abnormalities on light microscopy. However, canalicular dilatation, distortion, and loss of microvilli were present in the protoporphyrin-perfused livers examined by transmission electron microscopy. Although ultraviolet microscopy showed diffuse fluorescence of the hepatocytes and canaliculi of protoporphyrin-perfused livers, the deposition of protoporphyrin in amorphous or crystalline forms was notably absent in studies with polarizing and transmission electron microscopy. These studies provide evidence that protoporphyrin has hepatotoxic properties that affect the canalicular secretory apparatus. The mechanism(s) responsible for the injury require further clarification.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462423      PMCID: PMC370579          DOI: 10.1172/JCI110046

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Serum glutamic-oxaloacetic transaminase activity. A new modification and an anaytical assessment of current assay technics.

Authors:  E AMADOR; W E WACKER
Journal:  Clin Chem       Date:  1962-08       Impact factor: 8.327

2.  Changes in bile canaliculi produced by norethandrolone: electron microscopic study of human and rat liver.

Authors:  F SCHAFFNER; H POPPER; V PEREZ
Journal:  J Lab Clin Med       Date:  1960-10

3.  Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

Authors:  J R Bloomer; D A Brenner; M J Mahoney
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

4.  Hemodynamic effects on determinants of bile secretion in isolated rat liver.

Authors:  N Tavoloni; J S Reed; J L Boyer
Journal:  Am J Physiol       Date:  1978-06

5.  Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals.

Authors:  F Gschnait; K Konrad; H Hönigsmann; H Denk; K Wolff
Journal:  J Invest Dermatol       Date:  1975-09       Impact factor: 8.551

6.  Stimulation of hepatic sodium and potassium-activated adenosine triphosphatase activity by phenobarbital. Its possible role in regulation of bile flow.

Authors:  F R Simon; E Sutherland; L Accatino
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

7.  Gluconeogenesis in the perfused rat liver.

Authors:  R Hems; B D Ross; M N Berry; H A Krebs
Journal:  Biochem J       Date:  1966-11       Impact factor: 3.857

8.  Erythropoietic protoporphyria: hepatic cirrhosis.

Authors:  D J Cripps; S S Goldfarb
Journal:  Br J Dermatol       Date:  1978-03       Impact factor: 9.302

9.  Practical stereological methods for morphometric cytology.

Authors:  E R Weibel; G S Kistler; W F Scherle
Journal:  J Cell Biol       Date:  1966-07       Impact factor: 10.539

10.  A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells.

Authors:  A V Loud
Journal:  J Cell Biol       Date:  1968-04       Impact factor: 10.539

View more
  7 in total

1.  Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.

Authors:  J Bloomer; C Bruzzone; L Zhu; Y Scarlett; S Magness; D Brenner
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

2.  Effects of ion substitution on bile acid-dependent and -independent bile formation by rat liver.

Authors:  R W Van Dyke; J E Stephens; B F Scharschmidt
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

3.  Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria.

Authors:  Yongming Wang; Nathaniel B Langer; George C Shaw; Guang Yang; Liangtao Li; Jerry Kaplan; Barry H Paw; Joseph R Bloomer
Journal:  Exp Hematol       Date:  2011-05-11       Impact factor: 3.084

4.  Protoporphyrin overload in unrestrained rats: biochemical and histopathologic characterization of a new model of protoporphyric hepatopathy.

Authors:  M M Berenson; R Kimura; W Samowitz; D Bjorkman
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

5.  UK experience of liver transplantation for erythropoietic protoporphyria.

Authors:  Joanna K Dowman; Briget K Gunson; Darius F Mirza; Mike N Badminton; Philip N Newsome
Journal:  J Inherit Metab Dis       Date:  2011-02-08       Impact factor: 4.982

6.  Hepatic protoporphyrin metabolism in patients with advanced protoporphyric liver disease.

Authors:  J R Bloomer
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug

7.  Changes of Tight Junction Protein Claudins in Small Intestine and Kidney Tissues of Mice Fed a DDC Diet.

Authors:  Yukie Abiko; Takashi Kojima; Masaki Murata; Mitsuhiro Tsujiwaki; Masaya Takeuchi; Norimasa Sawada; Michio Mori
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.